Debt-to-equity of Cocrystal Pharma, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cocrystal Pharma, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Cocrystal Pharma, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 44%, a 112% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Cocrystal Pharma, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 44% +23% +112% 30 Sep 2025
Q2 2025 40% +25% +161% 30 Jun 2025
Q1 2025 32% +21% +196% 31 Mar 2025
Q4 2024 25% +16% +174% 31 Dec 2024
Q3 2024 21% +15% +267% 30 Sep 2024
Q2 2024 15% +10% +214% 30 Jun 2024
Q1 2024 11% +5.5% +104% 31 Mar 2024
Q4 2023 9.2% +5.5% +149% 31 Dec 2023
Q3 2023 5.7% +2.4% +71% 30 Sep 2023
Q2 2023 4.9% +2% +68% 30 Jun 2023
Q1 2023 5.3% +2.8% +112% 31 Mar 2023
Q4 2022 3.7% +1% +37% 31 Dec 2022
Q3 2022 3.3% +0.46% +16% 30 Sep 2022
Q2 2022 2.9% -0.94% -24% 30 Jun 2022
Q1 2022 2.5% -2.7% -52% 31 Mar 2022
Q4 2021 2.7% -3.2% -55% 31 Dec 2021
Q3 2021 2.9% -4.8% -62% 30 Sep 2021
Q2 2021 3.9% -2.7% -41% 30 Jun 2021
Q1 2021 5.2% +0.23% +4.6% 31 Mar 2021
Q4 2020 5.9% +1.6% +36% 31 Dec 2020
Q3 2020 7.6% +4.3% +132% 30 Sep 2020
Q2 2020 6.5% +0.38% +6.2% 30 Jun 2020
Q1 2020 5% -3.6% -42% 31 Mar 2020
Q4 2019 4.3% -7.1% -62% 31 Dec 2019
Q3 2019 3.3% -10% -76% 30 Sep 2019
Q2 2019 6.1% -10% -62% 30 Jun 2019
Q1 2019 8.5% -10% -54% 31 Mar 2019
Q4 2018 11% -8.9% -44% 31 Dec 2018
Q3 2018 14% -8.4% -38% 30 Sep 2018
Q2 2018 16% -9.3% -36% 30 Jun 2018
Q1 2018 19% -9.5% -34% 31 Mar 2018
Q4 2017 20% -10% -33% 31 Dec 2017
Q3 2017 22% -10% -32% 30 Sep 2017
Q2 2017 26% -8.1% -24% 30 Jun 2017
Q1 2017 28% -6.6% -19% 31 Mar 2017
Q4 2016 30% -6.7% -18% 31 Dec 2016
Q3 2016 33% -18% -35% 30 Sep 2016
Q2 2016 34% -26% -43% 30 Jun 2016
Q1 2016 35% -47% -58% 31 Mar 2016
Q4 2015 37% -658% -95% 31 Dec 2015
Q3 2015 50% +3201% 30 Sep 2015
Q2 2015 59% 30 Jun 2015
Q1 2015 82% 31 Mar 2015
Q4 2014 695% 31 Dec 2014
Q3 2014 -3151% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.